BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pomplun S, Sippel C, Hähle A, Tay D, Shima K, Klages A, Ünal CM, Rieß B, Toh HT, Hansen G, Yoon HS, Bracher A, Preiser P, Rupp J, Steinert M, Hausch F. Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins. J Med Chem 2018;61:3660-73. [PMID: 29578710 DOI: 10.1021/acs.jmedchem.8b00137] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Berthold EJ, Ma-lauer Y, Chakraborty A, von Brunn B, Hilgendorff A, Hatz R, Behr J, Hausch F, Staab-weijnitz CA, von Brunn A. Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models. Front Cell Infect Microbiol 2022;12:958634. [DOI: 10.3389/fcimb.2022.958634] [Reference Citation Analysis]
2 Rajan S, Yoon HS. Structural insights into Plasmodium PPIases. Front Cell Infect Microbiol 2022;12:931635. [DOI: 10.3389/fcimb.2022.931635] [Reference Citation Analysis]
3 Kolos JM, Pomplun S, Jung S, Rieß B, Purder PL, Voll AM, Merz S, Gnatzy M, Geiger TM, Quist-Løkken I, Jatzlau J, Knaus P, Holien T, Bracher A, Meyners C, Czodrowski P, Krewald V, Hausch F. Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides. Chem Sci 2021;12:14758-65. [PMID: 34820091 DOI: 10.1039/d1sc04638a] [Reference Citation Analysis]
4 Nehls T, Heymann T, Meyners C, Hausch F, Lermyte F. Fenton-Chemistry-Based Oxidative Modification of Proteins Reflects Their Conformation. Int J Mol Sci 2021;22:9927. [PMID: 34576105 DOI: 10.3390/ijms22189927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Smith-Sonneborn J. Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics. Curr Aging Sci 2020;13:11-21. [PMID: 31544708 DOI: 10.2174/1874609812666190620124324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Gnatzy MT, Geiger TM, Kuehn A, Gutfreund N, Walz M, Kolos JM, Hausch F. Development of NanoBRET-Binding Assays for FKBP-Ligand Profiling in Living Cells. Chembiochem 2021;22:2257-61. [PMID: 33887102 DOI: 10.1002/cbic.202100113] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Voll AM, Meyners C, Taubert MC, Bajaj T, Heymann T, Merz S, Charalampidou A, Kolos J, Purder PL, Geiger TM, Wessig P, Gassen NC, Bracher A, Hausch F. Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity. Angew Chem Int Ed Engl 2021;60:13257-63. [PMID: 33843131 DOI: 10.1002/anie.202017352] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Migliorini F, Dei F, Calamante M, Maramai S, Petricci E. Micellar Catalysis for Sustainable Hydroformylation. ChemCatChem 2021;13:2794-806. [DOI: 10.1002/cctc.202100181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bauder M, Meyners C, Purder PL, Merz S, Sugiarto WO, Voll AM, Heymann T, Hausch F. Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors. J Med Chem 2021;64:3320-49. [PMID: 33666419 DOI: 10.1021/acs.jmedchem.0c02195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Atack TC, Raymond DD, Blomquist CA, Pasaje CF, McCarren PR, Moroco J, Befekadu HB, Robinson FP, Pal D, Esherick LY, Ianari A, Niles JC, Sellers WR. Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35. ACS Med Chem Lett 2020;11:2131-8. [PMID: 33209191 DOI: 10.1021/acsmedchemlett.0c00272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Scheuplein NJ, Bzdyl NM, Kibble EA, Lohr T, Holzgrabe U, Sarkar-Tyson M. Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria. J Med Chem 2020;63:13355-88. [PMID: 32786507 DOI: 10.1021/acs.jmedchem.0c00911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Bischoff M, Mayer P, Meyners C, Hausch F. Enantioselective Synthesis of a Tricyclic, sp3 -Rich Diazatetradecanedione: an Amino Acid-Based Natural Product-Like Scaffold. Chemistry 2020;26:4677-81. [PMID: 31846111 DOI: 10.1002/chem.201905144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Deepa P, Thirumeignanam D. Understanding the potency of malarial ligand (D44) in plasmodium FKBP35 and modelled halogen atom (Br, Cl, F) functional groups. J Mol Graph Model 2020;97:107553. [PMID: 32035313 DOI: 10.1016/j.jmgm.2020.107553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Feng X, Sippel C, Knaup FH, Bracher A, Staibano S, Romano MF, Hausch F. A Novel Decalin-Based Bicyclic Scaffold for FKBP51-Selective Ligands. J Med Chem 2020;63:231-40. [PMID: 31800244 DOI: 10.1021/acs.jmedchem.9b01157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hähle A, Geiger TM, Merz S, Meyners C, Tianqi M, Kolos J, Hausch F. FKBP51 and FKBP12.6-Novel and tight interactors of Glomulin. PLoS One 2019;14:e0221926. [PMID: 31490997 DOI: 10.1371/journal.pone.0221926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Jagtap PKA, Asami S, Sippel C, Kaila VRI, Hausch F, Sattler M. Selective Inhibitors of FKBP51 Employ Conformational Selection of Dynamic Invisible States. Angew Chem Int Ed Engl 2019;58:9429-33. [PMID: 31100184 DOI: 10.1002/anie.201902994] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hähle A, Merz S, Meyners C, Hausch F. The Many Faces of FKBP51. Biomolecules 2019;9:E35. [PMID: 30669684 DOI: 10.3390/biom9010035] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
18 Kolos JM, Voll AM, Bauder M, Hausch F. FKBP Ligands-Where We Are and Where to Go? Front Pharmacol 2018;9:1425. [PMID: 30568592 DOI: 10.3389/fphar.2018.01425] [Cited by in Crossref: 30] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]